Unknown

Dataset Information

0

Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling.


ABSTRACT: Developing drugs that can effectively block STAT3 activation may serve as one of the most promising strategy for cancer treatment. Currently, there is no putative STAT3 inhibitor that can be safely and effectively used in clinic. In the present study, we investigated the potential of dihydroartemisinin (DHA) as a putative STAT3 inhibitor and its antitumor activities in head and neck squamous cell carcinoma (HNSCC). The inhibitory effects of DHA on STAT3 activation along with its underlying mechanisms were studied in HNSCC cells. The antitumor effects of DHA against HNSCC cells were explored both in vitro and in vivo. An investigation on cooperative effects of DHA with cisplatin in killing HNSCC cells was also implemented. DHA exhibited remarkable and specific inhibitory effects on STAT3 activation via selectively blocking Jak2/STAT3 signaling. Besides, DHA significantly inhibited HNSCC growth both in vitro and in vivo possibly through induction of apoptosis and attenuation of cell migration. DHA also synergized with cisplatin in tumor inhibition in HNSCC cells. Our findings demonstrate that DHA is a putative STAT3 inhibitor that may represent a new and effective drug for cancer treatment and therapeutic sensitization in HNSCC patients.

SUBMITTER: Jia L 

PROVIDER: S-EPMC4718674 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling.

Jia Lifeng L   Song Qi Q   Zhou Chenyang C   Li Xiaoming X   Pi Lihong L   Ma Xiuru X   Li Hui H   Lu Xiuying X   Shen Yupeng Y  

PloS one 20160119 1


Developing drugs that can effectively block STAT3 activation may serve as one of the most promising strategy for cancer treatment. Currently, there is no putative STAT3 inhibitor that can be safely and effectively used in clinic. In the present study, we investigated the potential of dihydroartemisinin (DHA) as a putative STAT3 inhibitor and its antitumor activities in head and neck squamous cell carcinoma (HNSCC). The inhibitory effects of DHA on STAT3 activation along with its underlying mecha  ...[more]

Similar Datasets

| S-EPMC6944621 | biostudies-literature
| S-EPMC4910719 | biostudies-literature
| S-EPMC3251692 | biostudies-other
| S-EPMC6843503 | biostudies-literature
| S-EPMC4930189 | biostudies-literature
| S-EPMC5805645 | biostudies-literature
| S-EPMC6410525 | biostudies-literature
| S-EPMC5581033 | biostudies-literature
| S-EPMC6485194 | biostudies-literature
| S-EPMC5041982 | biostudies-literature